4.6 Article

Application of single cell genomics to focal epilepsies: A call to action

Journal

BRAIN PATHOLOGY
Volume 31, Issue 4, Pages -

Publisher

WILEY
DOI: 10.1111/bpa.12958

Keywords

focal epilepsy; single cell genomics; somatic variant

Funding

  1. NIMH NIH HHS [U01 MH106883] Funding Source: Medline
  2. NINDS NIH HHS [R25 NS065743, R01 NS032457, R01 NS035129, L30 NS118655] Funding Source: Medline

Ask authors/readers for more resources

Single cell biology has revolutionized the study of neurological diseases by providing the granularity needed to investigate the consequences of somatic mosaicism in focal epilepsy research.
Focal epilepsies are the largest epilepsy subtype and associated with significant morbidity. Somatic variation is a newly recognized genetic mechanism underlying a subset of focal epilepsies, but little is known about the processes through which somatic mosaicism causes seizures, the cell types carrying the pathogenic variants, or their developmental origin. Meanwhile, the inception of single cell biology has completely revolutionized the study of neurological diseases and has the potential to answer some of these key questions. Focusing on single cell genomics, transcriptomics, and epigenomics in focal epilepsy research, circumvents the averaging artifact associated with studying bulk brain tissue and offers the kind of granularity that is needed for investigating the consequences of somatic mosaicism. Here we have provided a brief overview of some of the most developed single cell techniques and the major considerations around applying them to focal epilepsy research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available